date:Jun 25, 2014
Avoca, a division of Pharmachem Laboratories, has formed a supply agreement with Synthetic Genomics (SGI), a privately held company developing and commercialising genomic driven solutions and products in a variety of industries, to extract and commercialise natural astaxanthin from a strain of algae developed by SGI. The multi-year supply agreement also provides Avoca with exclusivity for product sales in North America. Pharmachem Laboratories will be responsible for marketing and sales. SGI is